58 related articles for article (PubMed ID: 22894736)
1. Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.
Reich R; Hoffman A; Veerendhar A; Maresca A; Innocenti A; Supuran CT; Breuer E
J Med Chem; 2012 Sep; 55(17):7875-82. PubMed ID: 22894736
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids.
Luisi G; Angelini G; Gasbarri C; Laghezza A; Agamennone M; Loiodice F; Supuran CT; Campestre C; Tortorella P
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1260-1264. PubMed ID: 28948845
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009.
Poulsen SA
Expert Opin Ther Pat; 2010 Jun; 20(6):795-806. PubMed ID: 20476848
[TBL] [Abstract][Full Text] [Related]
4. Carbamoylphosphonates inhibit autotaxin and metastasis formation in vivo.
Reich R; Hoffman A; Suresh RR; Shai O; Frant J; Maresca A; Supuran CT; Breuer E
J Enzyme Inhib Med Chem; 2015; 30(5):767-72. PubMed ID: 25669348
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway.
Hsieh MJ; Chen KS; Chiou HL; Hsieh YS
Eur J Cell Biol; 2010 Aug; 89(8):598-606. PubMed ID: 20434230
[TBL] [Abstract][Full Text] [Related]
6. Designing of novel carbonic anhydrase inhibitors and activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas.
Lounnas N; Rosilio C; Nebout M; Mary D; Griessinger E; Neffati Z; Chiche J; Spits H; Hagenbeek TJ; Asnafi V; Poulsen SA; Supuran CT; Peyron JF; Imbert V
Cancer Lett; 2013 Jun; 333(1):76-88. PubMed ID: 23348702
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II.
Carta F; Maresca A; Scozzafava A; Vullo D; Supuran CT
Bioorg Med Chem; 2009 Oct; 17(20):7093-9. PubMed ID: 19773173
[TBL] [Abstract][Full Text] [Related]
9. Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity.
Marques SM; Enyedy EA; Supuran CT; Krupenko NI; Krupenko SA; Santos MA
Bioorg Med Chem; 2010 Jul; 18(14):5081-9. PubMed ID: 20580561
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions.
Innocenti A; Vullo D; Pastorek J; Scozzafava A; Pastorekova S; Nishimori I; Supuran CT
Bioorg Med Chem Lett; 2007 Mar; 17(6):1532-7. PubMed ID: 17257840
[TBL] [Abstract][Full Text] [Related]
14. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?
De Simone G; Scozzafava A; Supuran CT
Chem Biol Drug Des; 2009 Sep; 74(3):317-21. PubMed ID: 19703035
[TBL] [Abstract][Full Text] [Related]
15. Membrane-bound carbonic anhydrases in osteoclasts.
Riihonen R; Supuran CT; Parkkila S; Pastorekova S; Väänänen HK; Laitala-Leinonen T
Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
[TBL] [Abstract][Full Text] [Related]
16. Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases.
Lopez M; Bornaghi LF; Innocenti A; Vullo D; Charman SA; Supuran CT; Poulsen SA
J Med Chem; 2010 Apr; 53(7):2913-26. PubMed ID: 20201556
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of glycoconjugate carbonic anhydrase inhibitors by ruthenium-catalysed azide-alkyne 1,3-dipolar cycloaddition.
Salmon AJ; Williams ML; Maresca A; Supuran CT; Poulsen SA
Bioorg Med Chem Lett; 2011 Oct; 21(20):6058-61. PubMed ID: 21903393
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II.
Stiti M; Cecchi A; Rami M; Abdaoui M; Barragan-Montero V; Scozzafava A; Guari Y; Winum JY; Supuran CT
J Am Chem Soc; 2008 Dec; 130(48):16130-1. PubMed ID: 18989963
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Org Biomol Chem; 2008 Jul; 6(14):2499-506. PubMed ID: 18600270
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties.
Colinas PA; Bravo RD; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Sep; 17(18):5086-90. PubMed ID: 17658252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
